Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burt Nabors

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Neuro-Oncology|October 11, 2022
The road we travelBurt Nabors
Neuro-Oncology|September 19, 2025
"Successful use of response leads to ONC201 approval"Louis Burt Nabors
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
The role of bevacizumab in glioblastomaL Burt Nabors
Current Treatment Options in Oncology|October 29, 2004
Targeted molecular therapy for malignant gliomasL Burt Nabors
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
Central Nervous System: Notable Developments in the Management of Primary and Recurrent GliomasLouis Burt Nabors
Neuro-Oncology|May 27, 2017
When less is better: care of the elderly with glioblastomaL Burt Nabors
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2017
Neuro-Oncology: Current Concepts and Emerging TherapeuticsBurt Nabors, John Laterra
Expert Review of Neurotherapeutics|July 20, 2005
Treatment of adults with recurrent malignant gliomaL Burt Nabors, John Fiveash
Neuro-Oncology|March 8, 2020
A troublesome burden, the amplification of EGFR in glioblastoma!Mina Lobbous, L Burt Nabors
Handbook of Clinical Neurology|March 8, 2016
Complications from pharmacotherapyL Burt Nabors, Birgit Surboeck, Wolfgang Grisold
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Neuro-Oncology|October 11, 2022
The road we travelBurt Nabors
Neuro-Oncology|September 19, 2025
"Successful use of response leads to ONC201 approval"Louis Burt Nabors
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
The role of bevacizumab in glioblastomaL Burt Nabors
Current Treatment Options in Oncology|October 29, 2004
Targeted molecular therapy for malignant gliomasL Burt Nabors
Journal of the National Comprehensive Cancer Network : JNCCN|May 27, 2016
Central Nervous System: Notable Developments in the Management of Primary and Recurrent GliomasLouis Burt Nabors
Neuro-Oncology|May 27, 2017
When less is better: care of the elderly with glioblastomaL Burt Nabors
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 12, 2017
Neuro-Oncology: Current Concepts and Emerging TherapeuticsBurt Nabors, John Laterra
Expert Review of Neurotherapeutics|July 20, 2005
Treatment of adults with recurrent malignant gliomaL Burt Nabors, John Fiveash
Neuro-Oncology|March 8, 2020
A troublesome burden, the amplification of EGFR in glioblastoma!Mina Lobbous, L Burt Nabors
Handbook of Clinical Neurology|March 8, 2016
Complications from pharmacotherapyL Burt Nabors, Birgit Surboeck, Wolfgang Grisold
Pageof 16